🚀 Welcome to our new website!
We’ve completely redesigned it to offer you a smoother, more intuitive and more enjoyable experience with enriched content. Explore what’s new and let us guide you! ✨
Support our Foundation of Myology project
INSTITUTE OF MYOLOGY
Research
MicroRNAs as Immune Regulators and Personalized Medicine Biomarkers in Myasthenia Gravis · Monday 16 November 2026 – from 12 to 1 pm · Dr. Paola…
Clinical activity
The 23rd Annual Conference of the French Society of Myology will take place from 18 to 20 November 2026 in Montpellier. The conference brings together…
Clinical activity
Chinese researchers have developed a new technique for screening for heterozygotes for infantile spinal muscular atrophy (SMA):
Clinical activity
As part of an international, multicentre observational study focusing on respiratory complications, clinicians analysed the outcomes of patients with myasthenia gravis during the COVID-19 pandemic:…
The Institute of Myology brings together 300 experts in muscle and muscle disease who have been dedicated for 30 years to muscle science and medicine, known as myology. Centred on the patient, this international centre of expertise coordinates activities in diagnosis, care, clinical research, evaluation, basic and applied research, and teaching.
Tailored care and long-term follow-up
for patients
Studying muscle and evaluating the efficacy of innovative therapies for patients
Understanding muscle and discovering new therapies for patients
Spreading knowledge about muscle and muscle disease and raising the profile of myology
OUR MISSION
Studying, diagnosing, evaluating and treating muscle and muscle disease, and promoting myology as a cross-cutting discipline for the benefit of as many people as possible.
Did you know?
Our muscles account for
40%
of our body mass
The Institute of Myology has two clinical trial platforms,
I-Motion Pediatric and I-Motion Adults.
I-Motion Pediatric is a clinical trial platform for children with neuromuscular diseases. It runs around 15 trials sponsored by academic or industry laboratories.
I-Motion Adults evaluates new treatments in adults with neuromuscular diseases. Around 40 trials are currently under way there.
600: that is the number of muscles in our body.
Beyond their role in motor function and movement, our muscles interact with many organs and are essential to our overall health.